EUVIMEDEUVIMED entdecken
Crossref

Stability‐Indicating RP‐HPLC Method Development and Validation for Determination of Impurities in Loperamide Hydrochloride Capsules Dosage Form

Sreenivas Pippalla iD, Vaishnavi Chintala iD

Biomedical Chromatography · 2025

DOI: 10.1002/bmc.70027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, 2025. Verfasst von Sreenivas Pippalla und 1 weiteren Autor:innen. Beteiligte Einrichtung: Sikkim Professional University Gangtok, Gangtok, Sikkim, India. Hauptthemen laut MEDLINE: Loperamide, Drug Contamination, Chromatography, Reverse-Phase. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A quality by design (QbD)‐based high‐resolution, stability‐indicating high‐performance liquid chromatography (HPLC) method was developed for determining impurities in loperamide hydrochloride (LPH) tablet dosage forms. Using this method, eight known impurities were qualified, and three degradants were quantified with excellent peak resolution. Mobile Phase‐A consisted of 0.05‐M tetrabutylammonium hydrogen phosphate buffer and acetonitrile (80:20, v/v), while Mobile Phase‐B contained the same buffer and acetonitrile (20:80, v/v). The gradient program was as follows: 0 min, MP‐A 95%, MP‐B 5%; 15 min, MP‐A 30%, MP‐B 70%; 17 min, MP‐A 30%, MP‐B 70%; 19 min, MP‐A 95%, MP‐B 5%; and 24 min, MP‐A 95%, MP‐B 5%. Chromatographic separation was performed using a column zodiac C18 (100 mm × 4.6 mm, 3.0 μm) with a flow rate of 1.5 mL/min, detection at 220 nm, an injection volume of 10 μL, and a column temperature of 35°C. Stress studies revealed LPH's sensitivity to acidic, oxidative, and thermal conditions. Under all forced degradation conditions, the purity angle was found to be less than the purity threshold, demonstrating the robustness of the method. Validation confirmed its suitability for quality analysis and stability studies in routine manufacturing processes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LoperamideDrug ContaminationChromatography, Reverse-PhaseChromatography, High Pressure LiquidDrug StabilityReproducibility of ResultsCapsulesLinear ModelsLimit of Detection

Stichwörter der Autor:innen

RP‐HPLCloperamide hydrochloride (LPH)method developmentmethod validationquality by design (QbD)

Substanzen

LoperamideCapsules

Autor:innen und Institutionen

  • Sikkim Professional University Gangtok, Gangtok, Sikkim, India.
  • Cambrex High Point, High Point, North Carolina, USA.

ORCID-Profile: Sreenivas Pippalla, Vaishnavi Chintala

Zitieren

APA

Pippalla, S., & Chintala, V. (2025). Stability‐Indicating RP‐HPLC Method Development and Validation for Determination of Impurities in Loperamide Hydrochloride Capsules Dosage Form. Biomedical Chromatography. https://doi.org/10.1002/bmc.70027

Vancouver

Pippalla S, Chintala V. Stability‐Indicating RP‐HPLC Method Development and Validation for Determination of Impurities in Loperamide Hydrochloride Capsules Dosage Form. Biomedical Chromatography. 2025. doi:10.1002/bmc.70027

BibTeX
@article{Pippalla2025,
  author = {Pippalla, Sreenivas and Chintala, Vaishnavi},
  title = {Stability‐Indicating RP‐HPLC Method Development and Validation for Determination of Impurities in Loperamide Hydrochloride Capsules Dosage Form},
  journal = {Biomedical Chromatography},
  year = {2025},
  doi = {10.1002/bmc.70027}
}
Kostenlos starten →